Articoli correlati a Retinal Degenerative Diseases: Mechanisms and Experimental...

Retinal Degenerative Diseases: Mechanisms and Experimental Therapy - Brossura

 
9781493952762: Retinal Degenerative Diseases: Mechanisms and Experimental Therapy
Vedi tutte le copie di questo ISBN:
 
 

Altre edizioni note dello stesso titolo

9781461432081: Retinal Degenerative Diseases: Mechanisms and Experimental Therapy: 801

Edizione in evidenza

ISBN 10:  1461432081 ISBN 13:  9781461432081
Casa editrice: Springer Nature, 2014
Rilegato

I migliori risultati di ricerca su AbeBooks

Immagini fornite dal venditore

Editore: Springer (2016)
ISBN 10: 1493952765 ISBN 13: 9781493952762
Nuovo Soft Cover Quantità: 10
Print on Demand
Da:
booksXpress
(Bayonne, NJ, U.S.A.)
Valutazione libreria

Descrizione libro Soft Cover. Condizione: new. This item is printed on demand. Codice articolo 9781493952762

Informazioni sul venditore | Contatta il venditore

Compra nuovo
EUR 307,04
Convertire valuta

Aggiungere al carrello

Spese di spedizione: GRATIS
In U.S.A.
Destinazione, tempi e costi
Immagini fornite dal venditore

Ash, John|Grimm, Christian|Hollyfield, Joe G.|Anderson, Robert E.|LaVail, Matthew M|Rickman, Catherine Bowes
Editore: Springer New York (2016)
ISBN 10: 1493952765 ISBN 13: 9781493952762
Nuovo Brossura Quantità: > 20
Print on Demand
Da:
moluna
(Greven, Germania)
Valutazione libreria

Descrizione libro Condizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Only proceedings of a very prestigious conferenceA comprehensive source for the latest basic research in the field of retinal degenerative diseasesEditorial Board comprises the most respected names in the fieldThis book will cont. Codice articolo 447956355

Informazioni sul venditore | Contatta il venditore

Compra nuovo
EUR 267,86
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 48,99
Da: Germania a: U.S.A.
Destinazione, tempi e costi
Foto dell'editore

John D. Ash
Editore: Springer (2016)
ISBN 10: 1493952765 ISBN 13: 9781493952762
Nuovo Brossura Quantità: > 20
Print on Demand
Da:
Ria Christie Collections
(Uxbridge, Regno Unito)
Valutazione libreria

Descrizione libro Condizione: New. PRINT ON DEMAND Book; New; Fast Shipping from the UK. No. book. Codice articolo ria9781493952762_lsuk

Informazioni sul venditore | Contatta il venditore

Compra nuovo
EUR 314,51
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 11,70
Da: Regno Unito a: U.S.A.
Destinazione, tempi e costi
Foto dell'editore

Editore: Springer (2016)
ISBN 10: 1493952765 ISBN 13: 9781493952762
Nuovo Brossura Quantità: > 20
Da:
Lucky's Textbooks
(Dallas, TX, U.S.A.)
Valutazione libreria

Descrizione libro Condizione: New. Codice articolo ABLIING23Mar2716030186732

Informazioni sul venditore | Contatta il venditore

Compra nuovo
EUR 331,66
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 3,72
In U.S.A.
Destinazione, tempi e costi
Immagini fornite dal venditore

John D. Ash
ISBN 10: 1493952765 ISBN 13: 9781493952762
Nuovo Taschenbuch Quantità: 2
Print on Demand
Da:
BuchWeltWeit Ludwig Meier e.K.
(Bergisch Gladbach, Germania)
Valutazione libreria

Descrizione libro Taschenbuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -This book will contain the proceedings of the XV International Symposium on Retinal Degeneration (RD2012). A majority of those who will speak and present posters at the meeting will contribute to this volume. The blinding diseases of inherited retinal degenerations have no treatments, and age-related macular degeneration has no cures, despite the fact that it is an epidemic among the elderly, with 1 in 3-4 affected by the age of 70. The RD Symposium will focus on the exciting new developments aimed at understanding these diseases and providing therapies for them. Since most major scientists in the field of retinal degenerations attend the biennial RD Symposia, they are known by most as the 'best' and 'most important' meetings in the field. The volume will present representative state-of-the-art research in almost all areas of retinal degenerations, ranging from cytopathologic, physiologic, diagnostic and clinical aspects; animal models; mechanisms of cell death; candidate genes, cloning, mapping and other aspects of molecular genetics; and developing potential therapeutic measures such as gene therapy and neuroprotective agents for potential pharmaceutical therapy. While advances in these areas of retinal degenerations will be described, there will be many new topics that either were in their infancy or did not exist at the time of the last RD Symposium, RD2010. These include the role of inflammation and immunity, as well as other basic mechanisms, in age-related macular degeneration, several new aspects of gene therapy, and revolutionary new imaging and functional testing that will have a huge impact on the diagnosis and following the course of retinal degenerations, as well as to provide new quantitative endpoints for clinical trials. The retina is an approachable part of the central nervous system (CNS), and there is a major interest in neuroprotective and gene therapy for CNS diseases and neurodegenerations, in general. It should be noted that with successful and exciting initial clinical trials in neuroprotective and gene therapy, including the restoration of sight in blind children, the retinal degeneration therapies are leading the way towards new therapeutic measures for neurodegenerations of the CNS. Many of the successes recently reported in these areas of retinal degeneration sprang from collaborations established at previous RD Symposia, and many of those will be reported at the RD2010 meeting and included in the proposed volume. We anticipate the excitement of those working in the field and those afflicted with retinal degenerations will be reflected in the volume. 924 pp. Englisch. Codice articolo 9781493952762

Informazioni sul venditore | Contatta il venditore

Compra nuovo
EUR 320,99
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 23,00
Da: Germania a: U.S.A.
Destinazione, tempi e costi
Immagini fornite dal venditore

John D. Ash
Editore: Springer New York (2016)
ISBN 10: 1493952765 ISBN 13: 9781493952762
Nuovo Taschenbuch Quantità: 1
Da:
AHA-BUCH GmbH
(Einbeck, Germania)
Valutazione libreria

Descrizione libro Taschenbuch. Condizione: Neu. Druck auf Anfrage Neuware - Printed after ordering - This book will contain the proceedings of the XV International Symposium on Retinal Degeneration (RD2012). A majority of those who will speak and present posters at the meeting will contribute to this volume. The blinding diseases of inherited retinal degenerations have no treatments, and age-related macular degeneration has no cures, despite the fact that it is an epidemic among the elderly, with 1 in 3-4 affected by the age of 70. The RD Symposium will focus on the exciting new developments aimed at understanding these diseases and providing therapies for them. Since most major scientists in the field of retinal degenerations attend the biennial RD Symposia, they are known by most as the 'best' and 'most important' meetings in the field. The volume will present representative state-of-the-art research in almost all areas of retinal degenerations, ranging from cytopathologic, physiologic, diagnostic and clinical aspects; animal models; mechanisms of cell death; candidate genes, cloning, mapping and other aspects of molecular genetics; and developing potential therapeutic measures such as gene therapy and neuroprotective agents for potential pharmaceutical therapy. While advances in these areas of retinal degenerations will be described, there will be many new topics that either were in their infancy or did not exist at the time of the last RD Symposium, RD2010. These include the role of inflammation and immunity, as well as other basic mechanisms, in age-related macular degeneration, several new aspects of gene therapy, and revolutionary new imaging and functional testing that will have a huge impact on the diagnosis and following the course of retinal degenerations, as well as to provide new quantitative endpoints for clinical trials. The retina is an approachable part of the central nervous system (CNS), and there is a major interest in neuroprotective and gene therapy for CNS diseases andneurodegenerations, in general. It should be noted that with successful and exciting initial clinical trials in neuroprotective and gene therapy, including the restoration of sight in blind children, the retinal degeneration therapies are leading the way towards new therapeutic measures for neurodegenerations of the CNS. Many of the successes recently reported in these areas of retinal degeneration sprang from collaborations established at previous RD Symposia, and many of those will be reported at the RD2010 meeting and included in the proposed volume. We anticipate the excitement of those working in the field and those afflicted with retinal degenerations will be reflected in the volume. Codice articolo 9781493952762

Informazioni sul venditore | Contatta il venditore

Compra nuovo
EUR 324,84
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 32,99
Da: Germania a: U.S.A.
Destinazione, tempi e costi
Foto dell'editore

Ash, John (Editor)/ Grimm, Christian (Editor)/ Hollyfield, Joe G. (Editor)/ Anderson, Robert E. (Editor)/ Lavail, Matthew M. (Editor)
Editore: Springer Verlag (2016)
ISBN 10: 1493952765 ISBN 13: 9781493952762
Nuovo Paperback Quantità: 2
Da:
Revaluation Books
(Exeter, Regno Unito)
Valutazione libreria

Descrizione libro Paperback. Condizione: Brand New. reprint edition. 923 pages. 9.25x6.10x1.93 inches. In Stock. Codice articolo x-1493952765

Informazioni sul venditore | Contatta il venditore

Compra nuovo
EUR 410,97
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 11,72
Da: Regno Unito a: U.S.A.
Destinazione, tempi e costi